Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia

    Portia Lagmay‐Fuentes, Andrea Smith, Shannon Krus, Laurie Lewis, Asma Latif, Tiffany Gagliardo, Manpreet K. Kohli
    TLDR Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.
    Scalp cooling (SC) devices, which are FDA-cleared, have been effective in preventing or reducing chemotherapy-induced alopecia (CIA). The paper discusses the implementation of a new Insurance-Based Billing Model in the USA for SC, which offers significant benefits over the original self-pay model. This change in compensation is expected to provide equitable healthcare access to all patients, including underserved and disadvantaged populations, by making this supportive care technology more widely available.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    3 / 3 results